Ftse Mib
36.326,95
0,35%
DAX
21.331,90
-0,25%
S&P 500
6.011,96
-1,46%
NASDAQ
19.449,25
-2,53%
Bitcoin
101.301,64
-3,22%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sangamo Therapeutics Inc (SGMO) Sangamo Therapeutics Inc (SGMO) Notizie

Sangamo Therapeutics Inc

SGMO
1,17
0,01 (0,86%)
Ultimo aggiornamento: 16:29:28
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202522:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/12/202422:23EDGAR2Form 8-K - Current report
30/12/202422:15BWSangamo Therapeutics to Regain Full Rights to Hemophilia A..
19/12/202408:30PRNUSAstellas and Sangamo Therapeutics Announce Capsid License..
26/11/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
19/11/202422:15BWSangamo Therapeutics Announces U.S. FDA Clearance of IND..
12/11/202423:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/11/202423:24EDGAR2Form S-3 - Registration statement under Securities Act of..
12/11/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:01EDGAR2Form 8-K - Current report
12/11/202422:01BWSangamo Therapeutics Reports Recent Business Highlights and..
04/11/202422:15BWSangamo Therapeutics Announces Third Quarter 2024 Conference..
28/10/202421:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
22/10/202414:05BWSangamo Therapeutics Announces Alignment With FDA on..
04/10/202422:03EDGAR2Form 8-K - Current report
27/8/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/8/202422:01BWSangamo Therapeutics Reports Recent Business Highlights and..
06/8/202414:05BWSangamo Therapeutics Announces Global Epigenetic Regulation..
30/7/202422:15BWSangamo Therapeutics Announces Second Quarter 2024..
24/7/202422:05EDGAR2Form 8-K - Current report
24/7/202412:55BWSangamo Therapeutics Reports on Pfizer’s Announcement of..
08/7/202422:32EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/6/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202423:10EDGAR2Form 8-K - Current report
29/5/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202423:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,12 Min: 1,12 Max: 1,21
Chiusura: 1,16

La tua Cronologia

NASDAQ
SGMO
Sangamo Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network